PT  - JOURNAL ARTICLE
AU  - Daniel L Herzberg
AU  - Harry P Sukumaran
AU  - Eugene Viscusi
TI  - NSAIDs for analgesia in the era of COVID-19
AID  - 10.1136/rapm-2020-101584
DP  - 2020 Jun 03
TA  - Regional Anesthesia & Pain Medicine
PG  - rapm-2020-101584
4099  - http://rapm.bmj.com/content/early/2020/06/03/rapm-2020-101584.short
4100  - http://rapm.bmj.com/content/early/2020/06/03/rapm-2020-101584.full
AB  - Globally, non-steroidal anti-inflammatory drugs (NSAIDs) are highly used to treat pain. With the rise of the COVID-19 pandemic, the safety of NSAIDs use has been called into question. These concerns are worthy of review. At present, there is no compelling data showing that NSAIDs worsen the severity of COVID-19 symptoms or increase one’s likelihood of contracting the illness. For patients in pain and without symptoms that could potentially be attributed to COVID-19 (cough, fevers/chills, lethargy, myalgias, anosmia and so on), NSAIDs should continue to remain a viable option to provide analgesia to patients in need.